Search research articles
Contact Us
Filters
Showing results (481-490 of 518) with videos related to
Page
of 52
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 11, 2026
Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point sampling
Ayako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 2, 2025
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring
Ayako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh, et al.
Pharmaceutical Research
|
October 21, 2024
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
Ayako Suzuki, Masaru Samura, Tomoyuki Ishigo, et al.
Plos One
|
December 2, 2015
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy
Yosuke Tanaka, Kazuhiko Aoyagi, Keiko Minashi, et al.
The Journal of Pharmacy and Pharmacology
|
June 16, 2025
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
February 14, 2024
Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer
Tomonori Yano, Yoshito Hayashi, Ryu Ishihara, et al.
Microbiology Spectrum
|
May 22, 2024
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, et al.
AJNR. American Journal of Neuroradiology
|
July 21, 2025
Digital FDG-PET detects <i>MYD88</i> mutation-driven glycolysis in primary central nervous system lymphoma
Mayu Sasaki, Yuri Teraoka, Ayumi Kato, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 24, 2025
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients
Toshiaki Komatsu, Atsushi Tomizawa, Masaru Samura, et al.
Page
of 52
Search research articles
Search
Showing results (481-490 of 518) with videos related to
Sort By:
Page
of 52
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 11, 2026
Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point sampling
Ayako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 2, 2025
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring
Ayako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh, et al.
Pharmaceutical Research
|
October 21, 2024
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
Ayako Suzuki, Masaru Samura, Tomoyuki Ishigo, et al.
Plos One
|
December 2, 2015
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy
Yosuke Tanaka, Kazuhiko Aoyagi, Keiko Minashi, et al.
The Journal of Pharmacy and Pharmacology
|
June 16, 2025
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
February 14, 2024
Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer
Tomonori Yano, Yoshito Hayashi, Ryu Ishihara, et al.
Microbiology Spectrum
|
May 22, 2024
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, et al.
AJNR. American Journal of Neuroradiology
|
July 21, 2025
Digital FDG-PET detects <i>MYD88</i> mutation-driven glycolysis in primary central nervous system lymphoma
Mayu Sasaki, Yuri Teraoka, Ayumi Kato, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 24, 2025
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients
Toshiaki Komatsu, Atsushi Tomizawa, Masaru Samura, et al.
Page
of 52